Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
Neoantigen Targeted Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neoantigen Targeted Therapy market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Colorectal Cancer and Renal Cell Carcinoma are the major drivers for the industry.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neoantigen Targeted Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report:
By Company
BioNTech SE
Gritstone Bio
Genocea Biosciences
Moderna
Agenus
Immatics
Advaxis
Precision Biologics
Gilead Sciences
Cellular Biomedicine Group
Achilles Therapeutics
Merck and Co
Beijing Kati Medical Technology
Segment by Type
Off-the-shelf Neoantigen
Personalized Neoantigen
Segment by Application
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung cancer
Bone Cancer
Gynecological Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neoantigen Targeted Therapy market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Neoantigen Targeted Therapy introduction, etc. Neoantigen Targeted Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Neoantigen Targeted Therapy market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.
1 Market Overview of Neoantigen Targeted Therapy
1.1 Neoantigen Targeted Therapy Market Overview
1.1.1 Neoantigen Targeted Therapy Product Scope
1.1.2 Neoantigen Targeted Therapy Market Status and Outlook
1.2 Global Neoantigen Targeted Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neoantigen Targeted Therapy Market Size by Region (2018-2029)
1.4 Global Neoantigen Targeted Therapy Historic Market Size by Region (2018-2023)
1.5 Global Neoantigen Targeted Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.1 North America Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.2 Europe Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.4 Latin America Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Neoantigen Targeted Therapy Market Size (2018-2029)
2 Neoantigen Targeted Therapy Market by Type
2.1 Introduction
2.1.1 Off-the-shelf Neoantigen
2.1.2 Personalized Neoantigen
2.2 Global Neoantigen Targeted Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neoantigen Targeted Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
3 Neoantigen Targeted Therapy Market Overview by Application
3.1 Introduction
3.1.1 Colorectal Cancer
3.1.2 Renal Cell Carcinoma
3.1.3 Non-Small Cell Lung cancer
3.1.4 Bone Cancer
3.1.5 Gynecological Cancer
3.1.6 Others
3.2 Global Neoantigen Targeted Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neoantigen Targeted Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
4 Neoantigen Targeted Therapy Competition Analysis by Players
4.1 Global Neoantigen Targeted Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
4.3 Date of Key Players Enter into Neoantigen Targeted Therapy Market
4.4 Global Top Players Neoantigen Targeted Therapy Headquarters and Area Served
4.5 Key Players Neoantigen Targeted Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Neoantigen Targeted Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioNTech SE
5.1.1 BioNTech SE Profile
5.1.2 BioNTech SE Main Business
5.1.3 BioNTech SE Neoantigen Targeted Therapy Products, Services and Solutions
5.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 BioNTech SE Recent Developments
5.2 Gritstone Bio
5.2.1 Gritstone Bio Profile
5.2.2 Gritstone Bio Main Business
5.2.3 Gritstone Bio Neoantigen Targeted Therapy Products, Services and Solutions
5.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Gritstone Bio Recent Developments
5.3 Genocea Biosciences
5.3.1 Genocea Biosciences Profile
5.3.2 Genocea Biosciences Main Business
5.3.3 Genocea Biosciences Neoantigen Targeted Therapy Products, Services and Solutions
5.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Moderna Recent Developments
5.4 Moderna
5.4.1 Moderna Profile
5.4.2 Moderna Main Business
5.4.3 Moderna Neoantigen Targeted Therapy Products, Services and Solutions
5.4.4 Moderna Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Moderna Recent Developments
5.5 Agenus
5.5.1 Agenus Profile
5.5.2 Agenus Main Business
5.5.3 Agenus Neoantigen Targeted Therapy Products, Services and Solutions
5.5.4 Agenus Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Agenus Recent Developments
5.6 Immatics
5.6.1 Immatics Profile
5.6.2 Immatics Main Business
5.6.3 Immatics Neoantigen Targeted Therapy Products, Services and Solutions
5.6.4 Immatics Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Immatics Recent Developments
5.7 Advaxis
5.7.1 Advaxis Profile
5.7.2 Advaxis Main Business
5.7.3 Advaxis Neoantigen Targeted Therapy Products, Services and Solutions
5.7.4 Advaxis Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Advaxis Recent Developments
5.8 Precision Biologics
5.8.1 Precision Biologics Profile
5.8.2 Precision Biologics Main Business
5.8.3 Precision Biologics Neoantigen Targeted Therapy Products, Services and Solutions
5.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Precision Biologics Recent Developments
5.9 Gilead Sciences
5.9.1 Gilead Sciences Profile
5.9.2 Gilead Sciences Main Business
5.9.3 Gilead Sciences Neoantigen Targeted Therapy Products, Services and Solutions
5.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Gilead Sciences Recent Developments
5.10 Cellular Biomedicine Group
5.10.1 Cellular Biomedicine Group Profile
5.10.2 Cellular Biomedicine Group Main Business
5.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Products, Services and Solutions
5.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Cellular Biomedicine Group Recent Developments
5.11 Achilles Therapeutics
5.11.1 Achilles Therapeutics Profile
5.11.2 Achilles Therapeutics Main Business
5.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Products, Services and Solutions
5.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Achilles Therapeutics Recent Developments
5.12 Merck and Co
5.12.1 Merck and Co Profile
5.12.2 Merck and Co Main Business
5.12.3 Merck and Co Neoantigen Targeted Therapy Products, Services and Solutions
5.12.4 Merck and Co Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Merck and Co Recent Developments
5.13 Beijing Kati Medical Technology
5.13.1 Beijing Kati Medical Technology Profile
5.13.2 Beijing Kati Medical Technology Main Business
5.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Products, Services and Solutions
5.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Beijing Kati Medical Technology Recent Developments
6 North America
6.1 North America Neoantigen Targeted Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neoantigen Targeted Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neoantigen Targeted Therapy Market Dynamics
11.1 Neoantigen Targeted Therapy Industry Trends
11.2 Neoantigen Targeted Therapy Market Drivers
11.3 Neoantigen Targeted Therapy Market Challenges
11.4 Neoantigen Targeted Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Neoantigen Targeted Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Neoantigen Targeted Therapy Market Size Share by Region (2018-2023)
Table 4. Global Neoantigen Targeted Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Neoantigen Targeted Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Neoantigen Targeted Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Neoantigen Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Neoantigen Targeted Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Neoantigen Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Neoantigen Targeted Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Neoantigen Targeted Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
Table 39. Date of Key Players Enter into Neoantigen Targeted Therapy Market
Table 40. Global Neoantigen Targeted Therapy Key Players Headquarters and Area Served
Table 41. Neoantigen Targeted Therapy Product Solution and Service
Table 42. Global Neoantigen Targeted Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. BioNTech SE Basic Information List
Table 45. BioNTech SE Description and Business Overview
Table 46. BioNTech SE Neoantigen Targeted Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of BioNTech SE (2018-2023)
Table 48. BioNTech SE Recent Developments
Table 49. Gritstone Bio Basic Information List
Table 50. Gritstone Bio Description and Business Overview
Table 51. Gritstone Bio Neoantigen Targeted Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Gritstone Bio (2018-2023)
Table 53. Gritstone Bio Recent Developments
Table 54. Genocea Biosciences Basic Information List
Table 55. Genocea Biosciences Description and Business Overview
Table 56. Genocea Biosciences Neoantigen Targeted Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Genocea Biosciences (2018-2023)
Table 58. Genocea Biosciences Recent Developments
Table 59. Moderna Basic Information List
Table 60. Moderna Description and Business Overview
Table 61. Moderna Neoantigen Targeted Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Moderna (2018-2023)
Table 63. Moderna Recent Developments
Table 64. Agenus Basic Information List
Table 65. Agenus Description and Business Overview
Table 66. Agenus Neoantigen Targeted Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Agenus (2018-2023)
Table 68. Agenus Recent Developments
Table 69. Immatics Basic Information List
Table 70. Immatics Description and Business Overview
Table 71. Immatics Neoantigen Targeted Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Immatics (2018-2023)
Table 73. Immatics Recent Developments
Table 74. Advaxis Basic Information List
Table 75. Advaxis Description and Business Overview
Table 76. Advaxis Neoantigen Targeted Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Advaxis (2018-2023)
Table 78. Advaxis Recent Developments
Table 79. Precision Biologics Basic Information List
Table 80. Precision Biologics Description and Business Overview
Table 81. Precision Biologics Neoantigen Targeted Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Precision Biologics (2018-2023)
Table 83. Precision Biologics Recent Developments
Table 84. Gilead Sciences Basic Information List
Table 85. Gilead Sciences Description and Business Overview
Table 86. Gilead Sciences Neoantigen Targeted Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Gilead Sciences (2018-2023)
Table 88. Gilead Sciences Recent Developments
Table 89. Cellular Biomedicine Group Basic Information List
Table 90. Cellular Biomedicine Group Description and Business Overview
Table 91. Cellular Biomedicine Group Neoantigen Targeted Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Cellular Biomedicine Group (2018-2023)
Table 93. Cellular Biomedicine Group Recent Developments
Table 94. Achilles Therapeutics Basic Information List
Table 95. Achilles Therapeutics Description and Business Overview
Table 96. Achilles Therapeutics Neoantigen Targeted Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Achilles Therapeutics (2018-2023)
Table 98. Achilles Therapeutics Recent Developments
Table 99. Merck and Co Basic Information List
Table 100. Merck and Co Description and Business Overview
Table 101. Merck and Co Neoantigen Targeted Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Merck and Co (2018-2023)
Table 103. Merck and Co Recent Developments
Table 104. Beijing Kati Medical Technology Basic Information List
Table 105. Beijing Kati Medical Technology Description and Business Overview
Table 106. Beijing Kati Medical Technology Neoantigen Targeted Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Beijing Kati Medical Technology (2018-2023)
Table 108. Beijing Kati Medical Technology Recent Developments
Table 109. North America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 110. North America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 111. Europe Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 112. Europe Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 113. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 114. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 115. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 116. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2018-2023)
Table 117. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2024-2029)
Table 118. Latin America Neoantigen Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 120. Latin America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 121. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 123. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 124. Neoantigen Targeted Therapy Market Trends
Table 125. Neoantigen Targeted Therapy Market Drivers
Table 126. Neoantigen Targeted Therapy Market Challenges
Table 127. Neoantigen Targeted Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neoantigen Targeted Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Neoantigen Targeted Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Neoantigen Targeted Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global Neoantigen Targeted Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Off-the-shelf Neoantigen
Figure 11. Global Off-the-shelf Neoantigen Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Personalized Neoantigen
Figure 13. Global Personalized Neoantigen Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Neoantigen Targeted Therapy Market Size Share by Type: 2022 & 2029
Figure 15. North America Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 16. Europe Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 20. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Renal Cell Carcinoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Non-Small Cell Lung cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Bone Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Gynecological Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Global Neoantigen Targeted Therapy Market Size Share by Application: 2022 & 2029
Figure 27. North America Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 28. Europe Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 29. Asia-Pacific Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 30. Latin America Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 31. Middle East and Africa Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 32. Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Neoantigen Targeted Therapy Market Share in 2022
Figure 34. North America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 35. United States Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 36. Canada Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 37. Germany Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. France Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. U.K. Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 40. Italy Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. Russia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 42. Nordic Countries Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2018-2029)
Figure 44. China Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 45. Japan Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 46. South Korea Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. India Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 49. Australia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 50. Latin America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 51. Mexico Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 52. Brazil Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 54. Turkey Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 56. UAE Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report
Related Reports
Global Drug Discovery and Development Services Market Research Report 2023
USD 2900.00 ?Single License?
USD 5800.00 ?Enterprise License?
Buy Now
Neoantigen Targeted Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neoantigen Targeted Therapy market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Colorectal Cancer and Renal Cell Carcinoma are the major drivers for the industry.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neoantigen Targeted Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report:
By Company
BioNTech SE
Gritstone Bio
Genocea Biosciences
Moderna
Agenus
Immatics
Advaxis
Precision Biologics
Gilead Sciences
Cellular Biomedicine Group
Achilles Therapeutics
Merck and Co
Beijing Kati Medical Technology
Segment by Type
Off-the-shelf Neoantigen
Personalized Neoantigen
Segment by Application
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung cancer
Bone Cancer
Gynecological Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neoantigen Targeted Therapy market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Neoantigen Targeted Therapy introduction, etc. Neoantigen Targeted Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Neoantigen Targeted Therapy market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.
1 Market Overview of Neoantigen Targeted Therapy
1.1 Neoantigen Targeted Therapy Market Overview
1.1.1 Neoantigen Targeted Therapy Product Scope
1.1.2 Neoantigen Targeted Therapy Market Status and Outlook
1.2 Global Neoantigen Targeted Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neoantigen Targeted Therapy Market Size by Region (2018-2029)
1.4 Global Neoantigen Targeted Therapy Historic Market Size by Region (2018-2023)
1.5 Global Neoantigen Targeted Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.1 North America Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.2 Europe Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.4 Latin America Neoantigen Targeted Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Neoantigen Targeted Therapy Market Size (2018-2029)
2 Neoantigen Targeted Therapy Market by Type
2.1 Introduction
2.1.1 Off-the-shelf Neoantigen
2.1.2 Personalized Neoantigen
2.2 Global Neoantigen Targeted Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neoantigen Targeted Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neoantigen Targeted Therapy Revenue Breakdown by Type (2018-2029)
3 Neoantigen Targeted Therapy Market Overview by Application
3.1 Introduction
3.1.1 Colorectal Cancer
3.1.2 Renal Cell Carcinoma
3.1.3 Non-Small Cell Lung cancer
3.1.4 Bone Cancer
3.1.5 Gynecological Cancer
3.1.6 Others
3.2 Global Neoantigen Targeted Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neoantigen Targeted Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neoantigen Targeted Therapy Revenue Breakdown by Application (2018-2029)
4 Neoantigen Targeted Therapy Competition Analysis by Players
4.1 Global Neoantigen Targeted Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
4.3 Date of Key Players Enter into Neoantigen Targeted Therapy Market
4.4 Global Top Players Neoantigen Targeted Therapy Headquarters and Area Served
4.5 Key Players Neoantigen Targeted Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Neoantigen Targeted Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioNTech SE
5.1.1 BioNTech SE Profile
5.1.2 BioNTech SE Main Business
5.1.3 BioNTech SE Neoantigen Targeted Therapy Products, Services and Solutions
5.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 BioNTech SE Recent Developments
5.2 Gritstone Bio
5.2.1 Gritstone Bio Profile
5.2.2 Gritstone Bio Main Business
5.2.3 Gritstone Bio Neoantigen Targeted Therapy Products, Services and Solutions
5.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Gritstone Bio Recent Developments
5.3 Genocea Biosciences
5.3.1 Genocea Biosciences Profile
5.3.2 Genocea Biosciences Main Business
5.3.3 Genocea Biosciences Neoantigen Targeted Therapy Products, Services and Solutions
5.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Moderna Recent Developments
5.4 Moderna
5.4.1 Moderna Profile
5.4.2 Moderna Main Business
5.4.3 Moderna Neoantigen Targeted Therapy Products, Services and Solutions
5.4.4 Moderna Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Moderna Recent Developments
5.5 Agenus
5.5.1 Agenus Profile
5.5.2 Agenus Main Business
5.5.3 Agenus Neoantigen Targeted Therapy Products, Services and Solutions
5.5.4 Agenus Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Agenus Recent Developments
5.6 Immatics
5.6.1 Immatics Profile
5.6.2 Immatics Main Business
5.6.3 Immatics Neoantigen Targeted Therapy Products, Services and Solutions
5.6.4 Immatics Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Immatics Recent Developments
5.7 Advaxis
5.7.1 Advaxis Profile
5.7.2 Advaxis Main Business
5.7.3 Advaxis Neoantigen Targeted Therapy Products, Services and Solutions
5.7.4 Advaxis Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Advaxis Recent Developments
5.8 Precision Biologics
5.8.1 Precision Biologics Profile
5.8.2 Precision Biologics Main Business
5.8.3 Precision Biologics Neoantigen Targeted Therapy Products, Services and Solutions
5.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Precision Biologics Recent Developments
5.9 Gilead Sciences
5.9.1 Gilead Sciences Profile
5.9.2 Gilead Sciences Main Business
5.9.3 Gilead Sciences Neoantigen Targeted Therapy Products, Services and Solutions
5.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Gilead Sciences Recent Developments
5.10 Cellular Biomedicine Group
5.10.1 Cellular Biomedicine Group Profile
5.10.2 Cellular Biomedicine Group Main Business
5.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Products, Services and Solutions
5.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Cellular Biomedicine Group Recent Developments
5.11 Achilles Therapeutics
5.11.1 Achilles Therapeutics Profile
5.11.2 Achilles Therapeutics Main Business
5.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Products, Services and Solutions
5.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Achilles Therapeutics Recent Developments
5.12 Merck and Co
5.12.1 Merck and Co Profile
5.12.2 Merck and Co Main Business
5.12.3 Merck and Co Neoantigen Targeted Therapy Products, Services and Solutions
5.12.4 Merck and Co Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Merck and Co Recent Developments
5.13 Beijing Kati Medical Technology
5.13.1 Beijing Kati Medical Technology Profile
5.13.2 Beijing Kati Medical Technology Main Business
5.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Products, Services and Solutions
5.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Beijing Kati Medical Technology Recent Developments
6 North America
6.1 North America Neoantigen Targeted Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neoantigen Targeted Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neoantigen Targeted Therapy Market Dynamics
11.1 Neoantigen Targeted Therapy Industry Trends
11.2 Neoantigen Targeted Therapy Market Drivers
11.3 Neoantigen Targeted Therapy Market Challenges
11.4 Neoantigen Targeted Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Neoantigen Targeted Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Neoantigen Targeted Therapy Market Size Share by Region (2018-2023)
Table 4. Global Neoantigen Targeted Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Neoantigen Targeted Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Neoantigen Targeted Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Neoantigen Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Neoantigen Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Neoantigen Targeted Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Neoantigen Targeted Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Neoantigen Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Neoantigen Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Neoantigen Targeted Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Neoantigen Targeted Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Neoantigen Targeted Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
Table 39. Date of Key Players Enter into Neoantigen Targeted Therapy Market
Table 40. Global Neoantigen Targeted Therapy Key Players Headquarters and Area Served
Table 41. Neoantigen Targeted Therapy Product Solution and Service
Table 42. Global Neoantigen Targeted Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. BioNTech SE Basic Information List
Table 45. BioNTech SE Description and Business Overview
Table 46. BioNTech SE Neoantigen Targeted Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of BioNTech SE (2018-2023)
Table 48. BioNTech SE Recent Developments
Table 49. Gritstone Bio Basic Information List
Table 50. Gritstone Bio Description and Business Overview
Table 51. Gritstone Bio Neoantigen Targeted Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Gritstone Bio (2018-2023)
Table 53. Gritstone Bio Recent Developments
Table 54. Genocea Biosciences Basic Information List
Table 55. Genocea Biosciences Description and Business Overview
Table 56. Genocea Biosciences Neoantigen Targeted Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Genocea Biosciences (2018-2023)
Table 58. Genocea Biosciences Recent Developments
Table 59. Moderna Basic Information List
Table 60. Moderna Description and Business Overview
Table 61. Moderna Neoantigen Targeted Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Moderna (2018-2023)
Table 63. Moderna Recent Developments
Table 64. Agenus Basic Information List
Table 65. Agenus Description and Business Overview
Table 66. Agenus Neoantigen Targeted Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Agenus (2018-2023)
Table 68. Agenus Recent Developments
Table 69. Immatics Basic Information List
Table 70. Immatics Description and Business Overview
Table 71. Immatics Neoantigen Targeted Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Immatics (2018-2023)
Table 73. Immatics Recent Developments
Table 74. Advaxis Basic Information List
Table 75. Advaxis Description and Business Overview
Table 76. Advaxis Neoantigen Targeted Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Advaxis (2018-2023)
Table 78. Advaxis Recent Developments
Table 79. Precision Biologics Basic Information List
Table 80. Precision Biologics Description and Business Overview
Table 81. Precision Biologics Neoantigen Targeted Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Precision Biologics (2018-2023)
Table 83. Precision Biologics Recent Developments
Table 84. Gilead Sciences Basic Information List
Table 85. Gilead Sciences Description and Business Overview
Table 86. Gilead Sciences Neoantigen Targeted Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Gilead Sciences (2018-2023)
Table 88. Gilead Sciences Recent Developments
Table 89. Cellular Biomedicine Group Basic Information List
Table 90. Cellular Biomedicine Group Description and Business Overview
Table 91. Cellular Biomedicine Group Neoantigen Targeted Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Cellular Biomedicine Group (2018-2023)
Table 93. Cellular Biomedicine Group Recent Developments
Table 94. Achilles Therapeutics Basic Information List
Table 95. Achilles Therapeutics Description and Business Overview
Table 96. Achilles Therapeutics Neoantigen Targeted Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Achilles Therapeutics (2018-2023)
Table 98. Achilles Therapeutics Recent Developments
Table 99. Merck and Co Basic Information List
Table 100. Merck and Co Description and Business Overview
Table 101. Merck and Co Neoantigen Targeted Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Merck and Co (2018-2023)
Table 103. Merck and Co Recent Developments
Table 104. Beijing Kati Medical Technology Basic Information List
Table 105. Beijing Kati Medical Technology Description and Business Overview
Table 106. Beijing Kati Medical Technology Neoantigen Targeted Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Neoantigen Targeted Therapy Business of Beijing Kati Medical Technology (2018-2023)
Table 108. Beijing Kati Medical Technology Recent Developments
Table 109. North America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 110. North America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 111. Europe Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 112. Europe Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 113. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 114. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 115. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 116. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2018-2023)
Table 117. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2024-2029)
Table 118. Latin America Neoantigen Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 120. Latin America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 121. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 123. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 124. Neoantigen Targeted Therapy Market Trends
Table 125. Neoantigen Targeted Therapy Market Drivers
Table 126. Neoantigen Targeted Therapy Market Challenges
Table 127. Neoantigen Targeted Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neoantigen Targeted Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Neoantigen Targeted Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Neoantigen Targeted Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global Neoantigen Targeted Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Off-the-shelf Neoantigen
Figure 11. Global Off-the-shelf Neoantigen Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Personalized Neoantigen
Figure 13. Global Personalized Neoantigen Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Neoantigen Targeted Therapy Market Size Share by Type: 2022 & 2029
Figure 15. North America Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 16. Europe Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2029)
Figure 20. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Renal Cell Carcinoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Non-Small Cell Lung cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Bone Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Gynecological Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Global Neoantigen Targeted Therapy Market Size Share by Application: 2022 & 2029
Figure 27. North America Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 28. Europe Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 29. Asia-Pacific Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 30. Latin America Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 31. Middle East and Africa Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2029)
Figure 32. Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Neoantigen Targeted Therapy Market Share in 2022
Figure 34. North America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 35. United States Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 36. Canada Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 37. Germany Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. France Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. U.K. Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 40. Italy Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. Russia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 42. Nordic Countries Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2018-2029)
Figure 44. China Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 45. Japan Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 46. South Korea Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. India Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 49. Australia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 50. Latin America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 51. Mexico Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 52. Brazil Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 54. Turkey Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 56. UAE Neoantigen Targeted Therapy Market Size (2018-2029) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report
Related Reports
Global Drug Discovery and Development Services Market Research Report 2023
USD 2900.00 ?Single License?
USD 5800.00 ?Enterprise License?
Buy Now
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.